Senior insider sale
Chief Operating Officer at X4 PHARMACEUTICALS, INC — senior position signals high conviction
$11.6K
22.26K shares
What this filing means
DIBIASE MARY plans to sell 22.26K shares of X4 PHARMACEUTICALS, INC valued at approximately $11.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/24/2025ACC: 0001973141-25-000041
Officer· Chief Operating Officer
Since Sep 2021
22.26K
Shares to sell
$11.6K
Approx. market value
22.26K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
PRSU Vesting
NA
1/23/2025
22.26KTotal acquired22.26K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/23/2025 | PRSU Vesting NA | 22.26K | — |
| Total | 22.26K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
22.26K
Market value
$11.6K
1/24/2025
Total
Units
22.26K
Value
$11.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
1/24/2025 | 22.26K | $11.6K | NASDAQ | Planned |
| Total | 22.26K | $11.6K | ||